Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Microba Life Sciences Ltd

MAP.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Healthcare Facilities & Services ·

Australia Micro Cap Analyst: STRONG BUY

Last Close

$0.04

▼ -3.51%

Market Cap $65.21M · Vol 127.00K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$65.21M

Micro Cap

Div Yield

N/A

EPS Growth

+34.46%

YoY

RSI (14)

63.16

Momentum

Beta

2.37

vs Market

52W High

$0.08

43.94% below

52W Low

$0.03

57.86% above

Volume

127.00K

Avg 201.04K

P/B

1.35

Price-to-book

ROE

-40.53%

Return on equity

Free Float

61.66%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Microba Life Sciences Ltd (MAP.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MAP.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.85%

+22.22%

-21.43%

-36.78%

YTD

-27.63%

-42.71%

-81.40%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$10.31M
Net Income	$-9,830,151.00
Revenue Growth (YoY)	-9.45%
Gross Margin	19.21%
Operating Margin	-157.05%
Net Profit Margin	-95.34%
ROE	-40.53%
ROA · ROIC	-28.36% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	2.43
P/B	1.35
P/FCF	N/A
EPS Growth	+34.46%
Outstanding Shares	717.12M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.05
RSI (14)	63.16
Beta	2.37
52-Week High	$0.08
52-Week Low	$0.03

Volume Today	127.00K
Avg Daily Volume (30D)	201.04K
Relative Volume	0.63x
Volatility (10D)	68.38
Volatility (30D)	65.69
Free Float	61.66%

Analyst Consensus

STRONG BUY

Current Price $0.04

Mean Target $0.08

52W Low$0.03 52W High$0.08

Current

Target

$0.03 $0.08

Current Analyst target

+114.28% upside potential · 1 analysts

Identifiers

ExchangeASX

FIGIBBG015D3M7M2

ISINAU0000209868

CountryAustralia

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateAug 28, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

NTRA Natera Inc -1.30% LH Labcorp Holdings Inc +0.89% RDNT RadNet Inc -2.77% LALPATHLAB.NS Dr. Lal PathLabs Ltd -0.55% WGS GeneDx Holdings Corp -2.15%

Company Profile

Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.